bis
Market Research Report

A quick peek into the report

Proteomics Market Report Coverage

Proteomics Market

Base Year

2023

Market Size in 2024

$33.92 Billion

Forecast Period

2024-2034

Value Projection and Estimation by 2034

$109.71 Billion

CAGR During Forecast Period

12.46%

Number of Pages

 176

Number of Tables

 88 Number of Figures 64

 

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the global proteomics market include:

•    Danaher Corporation
•    Thermo Fisher Scientific, Inc.
•    Agilent Technologies, Inc.
•    Bio-rad Laboratories
•    Revvity, Inc.
•    Illumina, Inc.
•    DiaSorin S.p.A.
•    Takara Bio Inc.
•    Merck KGaA

How can this report add value to an organization?

Product/Innovation Strategy: The global proteomics market has been extensively segmented based on various categories, such as offering, application, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years. 
Growth/Marketing Strategy: The new offering accounted for the maximum number of key developments in the global proteomics market between January 2022 and December 2024.

Competitive Strategy: The global proteomics market has numerous established players with product and service portfolios. Key players in the global proteomics market analyzed and profiled in the study involve established players offering proteomics products and services.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

•    Detailed secondary research was performed to ensure maximum coverage of manufacturers/suppliers operational in a country.
•    Exact revenue information, up to a certain extent, was extracted for each company from secondary sources and databases. The revenues specific to the offering, application, end user, and region were then estimated for each market player based on fact-based proxy indicators as well as primary inputs.
•    The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of proteomics.
•    The market contribution of the proteomics anticipated to be launched in the future has been calculated based on historical analysis. This analysis has been supported by proxy factors such as the innovation scale of the companies, the status of funding, collaborations, customer base, and patent scenario. 
•    The scope of availability of proteomics products and services in a particular region has been assessed based on a comprehensive analysis of companies’ prospects, regional end-user perception, and other factors impacting the launch of proteomics products and services in that region. 
•    The base year considered for the calculation of the market size is 2023. A historical year analysis has been done for the period FY2020-FY2022. The market size has been estimated for FY2023 and projected for the period FY2024-FY2034.
•    Revenues of the companies have been referenced from their annual reports for FY2020-FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, product approval status, market collaborations, and operational history.
•    Regional distribution of the market revenue has been estimated based on the companies in each region and the adoption rate of proteomics. All the numbers have been adjusted to a single digit after the decimal for better presentation in the report. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. The CAGR has been calculated for the period 2024-2034.
•    The market has been mapped based on the available proteomics. All the key companies with significant offerings in this field have been considered and profiled in this report. 
•    Market strategies and developments of key players have been considered for the calculation of the potential of the market in the forecast period.

Primary Research:

The primary sources involve industry experts in the proteomics market, including the market players offering proteomics solutions. Resources such as CXOs, vice presidents, product managers, directors, territory managers, and business development have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

•    Validation and triangulation of all the numbers and graphs
•    Validation of the report’s segmentation and key qualitative findings for proteomics
•    Understanding the competitive landscape and business model
•    Current and proposed production values of a product by market players
•    Validation of the numbers of the different segments of the market in focus
•    Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

•    European Medicines Agency (EMA), American Chemical Society (ACS), Frontiers, World Health Organization (WHO), and National Center for Biotechnology Information (NCBI), among others
•    Annual reports, SEC filings, and investor presentations of the leading market players
•    Company websites and detailed study of their portfolios
•    Gold standard magazines, journals, whitepapers, press releases, and news articles
•    Databases

The key data points taken from the secondary sources include:

•    Segmentation and percentage share estimates
•    Company and country understanding, and data for market value estimation
•    Key industry/market trends
•    Developments among top players 
•    Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
•    Quantitative data for mathematical and statistical calculations

 

Download this TOC

Request a Sample

Proteomics Market - A Global and Regional Analysis

Focus on Offerings, Application, End User, and Region - Analysis and Forecast, 2024-2034

Contact Us

Get Free Sample Schedule a Call
 
Some Faq's

Frequently Asked Questions

Proteomics is the large-scale study of proteins, focusing on their identification, function, structure, and interactions within biological systems. Proteins play vital roles in almost all cellular processes, such as enzyme catalysis, signaling, and immune response, making their study crucial for understanding biological functions and disease mechanisms. Unlike genomics, which examines genes, proteomics focuses on the functional aspects of proteins and how they contribute to cellular activities. Key aspects of proteomics include protein identification, quantification, studying post-translational modifications, and analyzing protein-protein interactions. This field is widely applied in areas such as drug discovery, biomarker identification, and personalized medicine, offering valuable insights into disease mechanisms and enabling the development of more targeted therapies.

New offerings accounted for the maximum number of key developments in the global proteomics market between January 2023 and December 2024. Key players such as Agilent Technologies, Inc., Danaher Corporation, Standard BioTools Inc., and Illumina, Inc. have been involved in synergistic activities to provide proteomics solutions, addressing the growing demand and engaging in various strategies to gain further market share.

The following are the USPs of this report:

•    Key trends 
•    Regulatory framework 
•    Patent analysis 
•    Competitive analysis based on a wide range of application
•    Active players in the proteomics ecosystem
•    Market dynamics (including drivers, restraints, and opportunities) and their impact analysis 
•    Region and country-level analysis, including market dynamics, market size, and forecast

This report on the proteomics market is valuable for a variety of stakeholders in the healthcare, biotechnology, pharmaceutical, and research sectors. Pharmaceutical and biotechnology companies can leverage it to identify emerging trends and key technological advancements in drug discovery and diagnostics.

Healthcare providers and medical institutions looking to adopt proteomics technologies for disease diagnostics and personalized medicine will benefit from the insights into market dynamics and technology adoption. Investors and venture capitalists seeking opportunities in the growing proteomics field can use the report to assess market growth and investment potential.

Academic and research institutions can stay updated on industry developments, while regulatory bodies and government agencies can gain insights into proteomics' role in clinical and research applications.

Additionally, proteomics technology providers and consulting firms in the life sciences sector will find this report crucial for making informed decisions and identifying new growth opportunities.